Transition Biotech
Refreshed on 2026-10-05 at the vendor’s request, from the live site, its WooCommerce Store API and the public COA library. Catalogue prices are current and in USD: eleven products, all in stock, nine of them single-vial peptides at $44.99–$54.99 per 10 mg vial, which puts the basket at 82.6% of the market median (93.8% in September). The index prices single vials only. Quantity pricing is offered on top of that — build-your-own bundles at 3–4 eligible vials for 10% off, 5–9 for 15%, 10 or more for up to 20% — and a wholesale programme for qualified laboratory and research organisations, reviewed and prepaid, with each SKU in multiples of ten and at least fifty eligible vials in total. Neither tier is shown as a single-vial price here. The COA library is unchanged since the September review: the same ten Kovera Labs certificates, one per product batch, all from a single July 2026 testing round, each printing the lot, purity, labelled and assayed mass; seven are recorded as compound records, the BPC-157/TB-500 blend states only a blend-average purity, and the two code-named products (TBT-2TZ, TBT-3RT) remain held because neither the listing nor the certificate names the compound and the vendor has asked that identity not be inferred from catalogue codes. Report KVR-2026-9CEBEB resolved on the laboratory’s own verify portal in September. Kovera Labs claims no accreditation, names no legal entity, and registered its domain on 2026-01-02, four weeks after the vendor’s. The vendor names Transition Biotech LLC and gives its location as Tampa, FL; the Wyoming registered-agent suite published in September no longer appears, so no street address is on record. Independent reviews: none found. Domain registered 2025-12-07.
Edited by Slava Melikov, Research Editor · reviewed 5 Oct 2026
Last verified · 7 certificate records · rubric v1.12.0 · transitionbiotech.com
Source: PepIndex, an independent index of research-peptide vendors. No vendor can pay for a rank, every score is computed by a published formula, and every figure links to the document it was read from.
PepIndex score
74.3 / 100
3.7/ 5Well documentedData coverage
87%
Coverage is the share of scored fields we hold and corroborated for Transition Biotech. A score built on a handful of unchecked claims and a score built on forty verified data points are not the same finding, so both numbers are always published together. How coverage is computed.
Is Transition Biotech legit?
Yes, on the evidence PepIndex holds. We have read 7 certificate records for Transition Biotech, all issued by Kovera Labs, and score it 74.3/100 on 87% data coverage — rank 16 of 57.
- Across those lots the mean assayed purity is 99.64%, and the weakest single lot came back at 99.37%.
- 1 of 7 lots assayed below the mass printed on the label.
- PepIndex checked the laboratory on those certificates, Kovera Labs, for ISO/IEC 17025 accreditation and found none on record.
- Its certificates can be read without an account, so anyone can check these figures.
- On the business side it publishes a named legal entity and prices visible without an account.
What this does not tell you
- PepIndex has located no independent customer reviews for Transition Biotech, so nothing here speaks to its service or fulfilment.
- A score measures what a vendor publishes about its testing and its business. It does not measure the contents of any vial a buyer actually receives, and PepIndex does not commission its own assays.
Certificate recordsLot-level results with labeled versus assayed mass7 lots6.3% mean deviationView all →Hide ↑
Discrepancy is computed as the absolute difference between labeled and assayed mass, divided by the labeled mass. A vendor-published certificate is a claim; only an independently commissioned assay is treated as corroboration.
| Compound | Lot | Tested | Lab | Labeled | Assayed | Discrepancy | Purity | Report |
|---|---|---|---|---|---|---|---|---|
| BPC-157 | BPC10-2607-01 | Kovera Labs | 10 mg | 11.07 mg | 10.7% | 99.6% | Vendor-published | |
| GHK-Cu | GHKCU100-2607-001 | Kovera Labs | 100 mg | 102.56 mg | 2.6% | 99.9% | Vendor-published | |
| Ipamorelin | IPA10-2607-01 | Kovera Labs | 10 mg | 10.47 mg | 4.7% | 99.7% | Vendor-published | |
| Kisspeptin | KISS10-2607-001 | Kovera Labs | 10 mg | 10.66 mg | 6.6% | 99.6% | Vendor-published | |
| NAD+ | NAD500-2607-001 | Kovera Labs | 500 mg | 492.76 mg | 1.4% | 99.4% | Vendor-published | |
| TB-500 | TB50010-2607-001 | Kovera Labs | 10 mg | 11.42 mg | 14.2% | 99.6% | Vendor-published | |
| CJC-1295 | CJCND10-2607-01 | Kovera Labs | 10 mg | 10.38 mg | 3.8% | 99.7% | Vendor-published |
Recorded data pointsEvery field with its source, capture date and whether we corroborated it8 verified9 claimed2 not recordedView all →Hide ↑
A tag of verified means we opened the cited source and confirmed the value; published means we recorded the vendor’s own published information, taken at face value. Both count in full; only a value with no checkable source earns nothing. Fields older than 30 days are marked stale.
Testing
- Testing laboratory
- Kovera LabsVerifiedStale23 Sept 2026sourceNamed on all 10 certificates ("tested by Kovera Labs"); report KVR-2026-9CEBEB resolved on koveralabs.com/verify with values matching the vendor-hosted copy. The lab states Buffalo Grove, IL, names no legal entity, claims no accreditation, and registered its domain on 2026-01-02.
- ISO/IEC 17025 accreditation
- NoVerifiedStale23 Sept 2026sourceNeither the vendor nor Kovera Labs claims ISO/IEC 17025 anywhere on their sites or certificates; the Disclosed Labs lab index records no A2LA/PJLA/ANAB/IAS/IAF entry for the lab. The vendor states in correspondence that it makes no accreditation claim.
- Certificate granularity
- Per batchVerifiedStale5 Oct 2026sourceOne certificate per product batch, with the batch reference printed beside each.
- Certificate accessibility
- publicVerifiedStale5 Oct 2026sourceCOA library is open, no account.
- Labeled vs. actual mg published
- YesVerifiedStale5 Oct 2026sourceEach certificate prints the labelled and the assayed mass (e.g. BPC-157 10 mg labelled, 11.07 mg found).
- Historical certificates retained
- Not recordedNot recorded
Business
- Website
- https://transitionbiotech.comVerifiedStale5 Oct 2026sourceLive on 2026-10-05.
- Legal entity
- Transition Biotech LLCPublishedStale5 Oct 2026sourceHome page, read 2026-10-05: "owned by Transition Biotech LLC". Not traced to a state filing.
- Country
- USVerifiedStale23 Sept 2026source"USA-Based & Veteran-Owned" band on every page; Wyoming LLC contact address, business location given as Tampa, FL; USD pricing and a Mountain Time shipping cutoff. The veteran-owned claim itself is not corroborated by any register.
- Physical address
- Not recordedNot recorded
- Contact channels
- Email (support@transitionbiotech.com), Email (info@transitionbiotech.com), Contact formPublishedStale5 Oct 2026sourceContact page, read 2026-10-05.
Commercial
- Pricing
- ungatedVerifiedStale5 Oct 2026sourcePrices open on the shop and the Store API, read 2026-10-05.
- Payment methods
- Visa, Mastercard, Apple Pay, Google PayPublishedStale5 Oct 2026sourceFooter and checkout notices, read 2026-10-05. "Bank payment (ACH)", recorded in September, no longer appears on any page.
- Guarantee / reship policy
- Case by casePublishedStale5 Oct 2026sourceRefund and return policy, read 2026-10-05: resolution by "refund, replacement, store credit, or other resolution" on review of the case.
Track record
- Independent reviews located
- Not recordedNot recorded
- Mean sentiment (0–5)
- Not recordedNot recorded
- Complaint pattern
- Not recordedNot recorded
Compounds carried
What Transition Biotech charges for each compound, read from its own store: the vial it lists, the price per milligram that implies, and that figure against the median of the vendors this index prices. Below 100% is cheaper than the market.
- CJC-12951 cert$5.50 /mg$54.99 for 10 mg61%Visit
- Wolverine$4.00 /mg$79.99 for 20 mg62%Visit
- Ipamorelin1 cert$4.50 /mg$44.99 for 10 mg73%Visit
- BPC-1571 cert$4.50 /mg$44.99 for 10 mg82%Visit
- GHK-Cu1 cert$0.50 /mg$49.99 for 100 mg83%Visit
- NAD+1 cert$0.11 /mg$54.99 for 500 mg92%Visit
- TB-5001 cert$5.50 /mg$54.99 for 10 mg92%Visit
- Kisspeptin1 cert$5.50 /mg$54.99 for 10 mg103%Visit
Score history
| First recorded | 82.4 · #112 Oct 2026 |
|---|---|
| Best rank | #112 Oct 2026 |
| Today | 74.3 · #16-8.1 since first recorded |
Strengths
- Publishes 10 certificates on its own site; 7 read and recorded here
- Certificates are readable publicly, without an account
- Testing laboratory named on certificates (Kovera Labs)
- Operates under a named legal entity (Transition Biotech LLC)
- Prices are visible without an account
Weaknesses
- No ISO/IEC 17025 accreditation recorded for the testing lab
- No physical postal address is published
- No independent third-party reviews located
Third-party reviews
Shown for reference and kept out of the score. Review platforms can be gamed — ratings bought, competitors brigaded, profiles removed — so nothing here is treated as evidence of what is in a vial. The score is computed from certificates and documentation alone.
- Trustpilot
- No profileread 1 Oct 2026
- Finnrick
- Not listedread 1 Oct 2026
Regulatory & enforcement record
No adverse regulatory or enforcement action on record. We record authority actions — FDA warning letters, import alerts, seizures, criminal charges — when located. Self-reported reviews are deliberately not scored, because for this market they can be manufactured.
How this score was calculatedEvery signal, its weight and the arithmetic — reconstructable by handrubric v1.12.0View calculation →Hide ↑
Each criterion is scored out of 100 over the signals we could assess, then weighted into the overall figure. Within a criterion, a signal contributes weight × merit × credit: merit is how good the recorded value is, credit is what its provenance earns — 1.00 for a value with a checkable source, 0 for a value recorded without one. A missing signal counts as a partial gap — half its weight — so a vendor that publishes what others leave blank scores higher, while a blank still costs; a value recorded without a source counts in full and earns nothing, so omitting one can never raise a score. A criterion with no data at all — price, when no price could be indexed — contributes nothing and its weight is not handed to the others, so an unmeasured dimension lowers the ceiling rather than disappearing; the coverage figure, shown alongside, reports how complete the assessment is. The weighted criteria sum to the evidence score; for a vendor published since the rule took effect, the published score is that figure times a tenure factor for time in the index, printed in the total below.
Testing transparency
64 / 100 · weight 26% → 16.6
Is the testing lab named? Is it ISO/IEC 17025 accredited? Are certificates of analysis lot-specific, and can anyone read them without an account?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Testing lab is namedA specific laboratory is identified, so the assay can be traced. | Kovera LabsNamed on all 10 certificates ("tested by Kovera Labs"); report KVR-2026-9CEBEB resolved on koveralabs.com/verify with values matching the vendor-hosted copy. The lab states Buffalo Grove, IL, names no legal entity, claims no accreditation, and registered its domain on 2026-01-02. | VerifiedStale23 Sept 2026 · source | 1 | 1.00 | 1.00 × 0.9 stale | 0.90 / 1 |
| Lab holds ISO/IEC 17025 accreditationNo accreditation recorded for the testing laboratory. | Not accreditedNeither the vendor nor Kovera Labs claims ISO/IEC 17025 anywhere on their sites or certificates; the Disclosed Labs lab index records no A2LA/PJLA/ANAB/IAS/IAF entry for the lab. The vendor states in correspondence that it makes no accreditation claim. | VerifiedStale23 Sept 2026 · source | 4 | 0.00 | 1.00 × 0.9 stale | 0.00 / 4 |
| Certificate granularityCertificates cover a batch rather than an individual lot. | Per batchOne certificate per product batch, with the batch reference printed beside each. | VerifiedStale5 Oct 2026 · source | 3 | 0.60 | 1.00 × 0.9 stale | 1.62 / 3 |
| Certificates readable without an accountAnyone, including us, can read the certificates without registering. | PublicCOA library is open, no account. | VerifiedStale5 Oct 2026 · source | 4 | 1.00 | 1.00 × 0.9 stale | 3.60 / 4 |
| Recognised testing laboratory7 of 7 certificates name a real, identifiable testing laboratory (a known lab, or a clearly independent one). Certificates with no named lab, or where the "lab" is just the vendor's own name, do not count — anyone can print those. | 7 / 7 recognised lab | PublishedStale22 Jul 2026 · source | 6 | 1.00 | 1.00 × 0.9 stale | 5.40 / 6 |
| Testing transparency subtotal · coverage 93% | 11.52 / 18 | |||||
Documentation depth
76.8 / 100 · weight 22% → 16.9
Does the vendor publish labeled-versus-actual milligram figures, retain historical certificates, and how large are the discrepancies we can measure?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Labeled vs. actual mg publishedQuantitative fill data is published, not only a purity percentage. | PublishedEach certificate prints the labelled and the assayed mass (e.g. BPC-157 10 mg labelled, 11.07 mg found). | VerifiedStale5 Oct 2026 · source | 1 | 1.00 | 1.00 × 0.9 stale | 0.90 / 1 |
| Historical certificates retainedNot recorded. | — | Not recorded | 3 | 0.00 | not recorded | 0.00 / 3 |
| Certificates the vendor publishes10 certificates located, 7 of them indexed with readable results; full credit at six. | 10 published, 7 indexed | PublishedStale22 Jul 2026 · source | 7 | 1.00 | 1.00 × 0.9 stale | 6.30 / 7 |
| Labeled vs. actual discrepancyMean absolute deviation between labeled and assayed mass across 7 certificates. Zero scores full marks; 10% or worse scores nothing. | 6.3% mean | PublishedStale22 Jul 2026 · source | 1 | 0.37 | 1.00 × 0.9 stale | 0.33 / 1 |
| Certificate recencyThe most recent certificate is dated 2026-07-22, about 4 months ago. Certificates within a year score full marks; two years or older scores nothing. | newest 2026-07-22 | PublishedStale22 Jul 2026 · source | 4 | 1.00 | 1.00 × 0.9 stale | 3.60 / 4 |
| Documentation depth subtotal · coverage 81% | 11.13 / 16 | |||||
Price & value
74.2 / 100 · weight 20% → 14.8
How the vendor’s per-milligram prices for a standard basket of common compounds compare to the market. Priced below the peer median scores higher; well above it scores lower. An overpriced vendor cannot outrank a comparably documented, better-priced one.
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Price vs market ($/mg)Priced about 17% below the peer median per milligram across a standard basket — better value than the typical vendor. | 83% of medianPrice index 82.6% of peer median across 6 compounds (0 outliers dropped): kisspeptin $5.5/mg, ghk-cu $0.5/mg, ipamorelin $4.5/mg, cjc-1295 $5.5/mg, tb-500 $5.5/mg, bpc-157 $4.5/mg. | VerifiedStale6 Oct 2026 · source | 10 | 0.82 | 1.00 × 0.9 stale | 7.42 / 10 |
| Price & value subtotal · coverage 90% | 7.42 / 10 | |||||
Track record
90 / 100 · weight 12% → 10.8
Adverse regulatory or enforcement action on record — warning letters, import alerts, seizures, criminal charges. Authority-issued and publicly verifiable. Self-reported reviews are deliberately not scored: for this market they can be manufactured.
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Regulatory & enforcement recordNo adverse regulatory or enforcement action on record. Authority actions — warning letters, import alerts, seizures, criminal charges — are recorded here when located; self-reported reviews are deliberately not scored, because for this market they can be manufactured. | None on recordChecked 2026-09-23: FDA warning-letter export for "transition biotech" returned no rows; not on Import Alert 66-41; no SAM.gov exclusion; no state action found by web search. | VerifiedStale23 Sept 2026 · source | 10 | 1.00 | 1.00 × 0.9 stale | 9.00 / 10 |
| Track record subtotal · coverage 90% | 9.00 / 10 | |||||
Business transparency
75 / 100 · weight 12% → 9
Is a legal entity named, is there a physical address, and can the vendor be reached?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Named legal entityA registered entity is named, so there is someone to hold responsible. | Transition Biotech LLCHome page, read 2026-10-05: "owned by Transition Biotech LLC". Not traced to a state filing. | PublishedStale5 Oct 2026 · source | 3 | 1.00 | 1.00 × 0.9 stale | 2.70 / 3 |
| Physical address publishedNot recorded. | — | Not recorded | 2 | 0.00 | not recorded | 0.00 / 2 |
| Contact channelsDistinct contact routes we could identify. Full credit at two. | Email (support@transitionbiotech.com), Email (info@transitionbiotech.com), Contact formContact page, read 2026-10-05. | PublishedStale5 Oct 2026 · source | 2 | 1.00 | 1.00 × 0.9 stale | 1.80 / 2 |
| Business transparency subtotal · coverage 71% | 4.50 / 7 | |||||
Commercial clarity
77.7 / 100 · weight 8% → 6.2
Is pricing visible without an account, is there a stated guarantee or reship policy, and are payment methods disclosed?
| Signal | Recorded value | Provenance | Weight | Merit | Credit | Points |
|---|---|---|---|---|---|---|
| Pricing visible without an accountPrices are published openly and can be compared. | UngatedPrices open on the shop and the Store API, read 2026-10-05. | VerifiedStale5 Oct 2026 · source | 4 | 1.00 | 1.00 × 0.9 stale | 3.60 / 4 |
| Guarantee / reship policyWhether the published policy states an outcome in advance or leaves it to discretion. | Case by caseRefund and return policy, read 2026-10-05: resolution by "refund, replacement, store credit, or other resolution" on review of the case. | PublishedStale5 Oct 2026 · source | 3 | 0.50 | 1.00 × 0.9 stale | 1.35 / 3 |
| Payment methods disclosedDisclosed payment routes. Full credit at three. | Visa, Mastercard, Apple Pay, Google PayFooter and checkout notices, read 2026-10-05. "Bank payment (ACH)", recorded in September, no longer appears on any page. | PublishedStale5 Oct 2026 · source | 1 | 1.00 | 1.00 × 0.9 stale | 0.90 / 1 |
| Payment offers buyer recourseAccepts a payment method with buyer recourse — cards or wallets a processor underwrote, so a chargeback is possible if an order goes wrong. | Card / recourseFooter and checkout notices, read 2026-10-05. "Bank payment (ACH)", recorded in September, no longer appears on any page. | PublishedStale5 Oct 2026 · source | 3 | 1.00 | 1.00 × 0.9 stale | 2.70 / 3 |
| Commercial clarity subtotal · coverage 96% | 8.55 / 11 | |||||
Total
| Criterion | Subscore | Weight | Contribution | Coverage |
|---|---|---|---|---|
| Testing transparency | 64 | 26% | 16.6 | 93% |
| Documentation depth | 76.8 | 22% | 16.9 | 81% |
| Price & value | 74.2 | 20% | 14.8 | 90% |
| Track record | 90 | 12% | 10.8 | 90% |
| Business transparency | 75 | 12% | 9 | 71% |
| Commercial clarity | 77.7 | 8% | 6.2 | 96% |
| Evidence scoreThe weighted criteria, before time in the index. | 100% | 74.3 | 87% | |
| Time in the indexPublished 2026-09-24, before the tenure rule took effect on 2026-10-30: the evidence score counts in full. The rule applies to vendors published from that date on. | day 49 | × 1.0000 | in full | |
| Computed score | 74.3 | 87% |
Rubric v1.12.0 · 8 verified, 9 claimed, 0 unsourced, 2 not recorded, 17 stale of 19 scored signals
Community
Reviews
Reader reviews are community context only — they are never part of Transition Biotech’s computed PepIndex score, which is built from evidence alone.
No reviews yet. .